Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicitas Thol

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemiaFelicitas Thol, Frederik Damm, Andrea Lüdeking, et al.
Nature Communications|January 15, 2015
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndromeVikas Madan, Deepika Kanojia, Jia Li, et al.
Cancers|September 30, 2020
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid LeukemiaSagarajit Mohanty, Nidhi Jyotsana, Amit Sharma, et al.
Nature Immunology|February 17, 2018
Publisher Correction: Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infectionSarina Ravens, Christian Schultze-Florey, Solaiman Raha, et al.
Nature Immunology|February 21, 2017
Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infectionSarina Ravens, Christian Schultze-Florey, Solaiman Raha, et al.
Haematologica|April 4, 2020
Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemiaAnuhar Chaturvedi, Charu Gupta, Razif Gabdoulline, et al.
Cancers|August 12, 2023
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AMLKatrin Teich, Michael Stadler, Razif Gabdoulline, et al.
Annals of Hematology|March 24, 2017
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemiaAnna Both, Jürgen Krauter, Frederik Damm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromesFelicitas Thol, Inna Friesen, Frederik Damm, et al.
Leukemia|September 19, 2020
IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysisBadder Kattih, Amir Shirvani, Piroska Klement, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemiaFelicitas Thol, Frederik Damm, Andrea Lüdeking, et al.
Nature Communications|January 15, 2015
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndromeVikas Madan, Deepika Kanojia, Jia Li, et al.
Cancers|September 30, 2020
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid LeukemiaSagarajit Mohanty, Nidhi Jyotsana, Amit Sharma, et al.
Nature Immunology|February 17, 2018
Publisher Correction: Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infectionSarina Ravens, Christian Schultze-Florey, Solaiman Raha, et al.
Nature Immunology|February 21, 2017
Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infectionSarina Ravens, Christian Schultze-Florey, Solaiman Raha, et al.
Haematologica|April 4, 2020
Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemiaAnuhar Chaturvedi, Charu Gupta, Razif Gabdoulline, et al.
Cancers|August 12, 2023
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AMLKatrin Teich, Michael Stadler, Razif Gabdoulline, et al.
Annals of Hematology|March 24, 2017
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemiaAnna Both, Jürgen Krauter, Frederik Damm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromesFelicitas Thol, Inna Friesen, Frederik Damm, et al.
Leukemia|September 19, 2020
IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysisBadder Kattih, Amir Shirvani, Piroska Klement, et al.
Pageof 13